Option Care Health, Inc. (NASDAQ:OPCH) Receives $35.10 Consensus PT from Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $35.10.

A number of brokerages have issued reports on OPCH. TD Cowen began coverage on shares of Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating and a $30.00 target price on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Wednesday, October 8th. Barrington Research restated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday, September 23rd. JMP Securities lifted their price target on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a report on Thursday, July 31st. Finally, Morgan Stanley assumed coverage on Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 target price on the stock.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the stock in a transaction on Wednesday, August 20th. The shares were purchased at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan purchased 20,000 shares of Option Care Health stock in a transaction dated Thursday, August 21st. The shares were purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares in the company, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 59,411 shares of company stock worth $1,627,576. Corporate insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Compass Wealth Management LLC increased its holdings in shares of Option Care Health by 8.9% during the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company’s stock worth $5,804,000 after buying an additional 13,600 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after purchasing an additional 599 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Option Care Health by 1.4% during the first quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock valued at $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Option Care Health by 25.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock valued at $289,000 after purchasing an additional 1,691 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of Option Care Health by 307.1% during the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock valued at $112,000 after purchasing an additional 2,408 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH stock opened at $28.29 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health has a one year low of $21.39 and a one year high of $35.53. The company’s 50-day simple moving average is $28.01 and its 200-day simple moving average is $30.18. The stock has a market capitalization of $4.59 billion, a price-to-earnings ratio of 22.63, a PEG ratio of 1.71 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same quarter last year, the company posted $0.30 earnings per share. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.